CBD of Denver Inc. (CBDD) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CBDD, $ (piyasa değeri 0) fiyatla Healthcare işi olan CBD of Denver Inc.'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 51/100 puan alıyor.
Son analiz: 16 Mar 2026CBD of Denver Inc. (CBDD) Sağlık ve Boru Hattı Genel Bakışı
CBD of Denver Inc. is a cannabidiol (CBD) product company involved in the research, development, and distribution of premium hemp extract products. Operating as a subsidiary of Swiss Industry Ventures AG, the company focuses on commercializing CBD products within the specialty and generic drug manufacturing sector.
Yatırım Tezi
CBD of Denver Inc. presents a speculative investment opportunity within the rapidly evolving CBD market. The company's focus on premium hemp extract products and its position as a subsidiary of Swiss Industry Ventures AG could provide a competitive edge. However, the company's financial performance and market capitalization of $0.00B indicate significant risks. A gross margin of 27.1% suggests potential profitability challenges. The negative beta of -10.69 indicates an inverse correlation with the market, which could be a double-edged sword. Growth catalysts include potential expansion into new product lines and geographic markets. Investors should carefully evaluate the company's OTC status and associated risks before considering an investment.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market Cap of $0.00B reflects the company's small size and potential volatility.
- Gross Margin of 27.1% indicates the profitability of CBDD's core operations.
- Beta of -10.69 suggests an inverse correlation with the broader market.
- CBDD operates as a subsidiary of Swiss Industry Ventures AG.
- CBDD focuses on the development and commercialization of cannabidiol (CBD) products.
Güçlü Yönler
- Focus on premium hemp extract products.
- Subsidiary of Swiss Industry Ventures AG.
- Established presence in the CBD market.
- Commitment to research and development.
Zayıflıklar
- Small market capitalization.
- Limited financial resources.
- Dependence on the CBD market.
- OTC market listing.
Katalizörler
- Upcoming: Potential expansion into new therapeutic areas.
- Upcoming: Geographic expansion into new markets.
- Upcoming: Development of innovative CBD products.
- Ongoing: Strategic partnerships and acquisitions.
- Ongoing: Focus on quality and compliance.
Riskler
- Potential: Intense competition in the CBD market.
- Potential: Evolving regulations and consumer preferences.
- Potential: Negative publicity or product recalls.
- Potential: Fluctuations in the price of hemp extract.
- Ongoing: Limited financial resources.
Büyüme Fırsatları
- Expansion into New Therapeutic Areas: CBD of Denver Inc. has the opportunity to expand its product line into new therapeutic areas, such as pain management, anxiety relief, and sleep disorders. The market for CBD-based therapeutic products is growing rapidly, driven by increasing consumer awareness and scientific research. By developing and commercializing targeted CBD formulations, CBD of Denver Inc. can tap into this lucrative market segment and differentiate itself from competitors. This expansion could involve partnerships with healthcare providers and research institutions. The timeline for this growth opportunity is estimated at 2-3 years, with a potential market size of $5 billion.
- Geographic Expansion: CBD of Denver Inc. can pursue geographic expansion into new markets, both domestically and internationally. The global CBD market is highly fragmented, with significant growth potential in emerging markets. By establishing distribution partnerships and tailoring its product offerings to local preferences, CBD of Denver Inc. can expand its reach and increase its revenue. This expansion could involve entering into joint ventures or acquiring local CBD companies. The timeline for this growth opportunity is estimated at 3-5 years, with a potential market size of $10 billion.
- Development of Innovative CBD Products: CBD of Denver Inc. can invest in research and development to create innovative CBD products with enhanced efficacy and bioavailability. This could involve developing novel formulations, delivery systems, and extraction methods. By patenting its innovations and establishing a strong intellectual property portfolio, CBD of Denver Inc. can gain a competitive advantage and attract strategic partners. The timeline for this growth opportunity is estimated at 2-4 years, with a potential market size of $3 billion.
- Strategic Partnerships and Acquisitions: CBD of Denver Inc. can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This could involve partnering with established healthcare companies, retailers, or distributors. By acquiring complementary businesses, CBD of Denver Inc. can gain access to new technologies, products, and distribution channels. The timeline for this growth opportunity is estimated at 1-3 years, with a potential market size of $2 billion.
- Focus on Quality and Compliance: CBD of Denver Inc. can differentiate itself by focusing on product quality and regulatory compliance. This involves implementing rigorous quality control measures, obtaining certifications, and adhering to all applicable regulations. By building a reputation for quality and compliance, CBD of Denver Inc. can gain the trust of consumers and healthcare providers. The timeline for this growth opportunity is ongoing, with a potential market size of $1 billion.
Fırsatlar
- Expansion into new therapeutic areas.
- Geographic expansion into new markets.
- Development of innovative CBD products.
- Strategic partnerships and acquisitions.
Tehditler
- Intense competition in the CBD market.
- Evolving regulations and consumer preferences.
- Potential for negative publicity or product recalls.
- Fluctuations in the price of hemp extract.
Rekabet Avantajları
- Proprietary CBD formulations and extraction methods.
- Established distribution network.
- Strong brand reputation for quality and compliance.
- Strategic partnerships with key players in the healthcare and wellness industries.
CBDD Hakkında
CBD of Denver Inc., formerly known as Verde Media Group, Inc., was rebranded in 2018 to focus on the burgeoning cannabidiol (CBD) market. The company is dedicated to the research, development, and commercialization of a range of CBD products. Its core business revolves around the creation and distribution of premium hemp extract products, catering to a growing demand for CBD-based solutions. Headquartered in Centennial, Colorado, CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG, leveraging its parent company's resources and expertise. The company's evolution reflects the increasing acceptance and market potential of CBD in various applications, from wellness to potential therapeutic uses. CBD of Denver Inc. aims to establish itself as a key player in the CBD market by focusing on product quality, innovation, and strategic distribution partnerships. The company's commitment to research and development underscores its ambition to stay at the forefront of CBD advancements and capitalize on emerging opportunities within the healthcare and wellness sectors. CBD of Denver Inc. distributes its products through various channels, targeting both retail consumers and potential business-to-business partnerships.
Ne Yaparlar
- Develops and commercializes cannabidiol (CBD) products.
- Engages in the research of hemp extract products.
- Distributes premium hemp extract products.
- Focuses on the wellness and potential therapeutic applications of CBD.
- Operates as a subsidiary of Swiss Industry Ventures AG.
- Aims to establish a strong presence in the CBD market.
İş Modeli
- Develops and formulates CBD products.
- Manufactures or outsources the production of CBD products.
- Distributes CBD products through various channels, including retail and online sales.
- Generates revenue from the sale of CBD products.
Sektör Bağlamı
CBD of Denver Inc. operates within the Drug Manufacturers - Specialty & Generic industry, which is experiencing significant growth due to the increasing acceptance and legalization of cannabis and CBD products. The market is characterized by intense competition, with numerous companies vying for market share. The industry is also subject to evolving regulations and consumer preferences. CBD of Denver Inc.'s success depends on its ability to differentiate its products, navigate the regulatory landscape, and establish strong distribution channels. The global CBD market is projected to reach billions of dollars in the coming years, presenting both opportunities and challenges for companies like CBD of Denver Inc.
Kilit Müşteriler
- Consumers seeking wellness and therapeutic benefits from CBD.
- Retailers and distributors of CBD products.
- Healthcare providers interested in CBD-based solutions.
- Businesses seeking to incorporate CBD into their products.
Finansallar
Grafik & Bilgi
CBD of Denver Inc. (CBDD) hisse senedi fiyatı: Price data unavailable
Son Haberler
CBDD için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
CBDD için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
CBDD için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, CBDD'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
CBDD OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that CBD of Denver Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, which increases investment risk. Investing in companies on the OTC Other tier requires a high degree of due diligence and risk tolerance due to the potential for fraud, lack of liquidity, and limited information availability. These companies are not required to be SEC reporting.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure.
- Potential for fraud or manipulation.
- Lack of liquidity.
- High price volatility.
- Limited regulatory oversight.
- Verify the company's management team and their track record.
- Review the company's financial statements, if available.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor.
- Confirm the company's good standing with the Secretary of State.
- Company is a subsidiary of Swiss Industry Ventures AG.
- Company has been in operation since 2018.
- Company focuses on a growing market segment (CBD).
- Company has a defined business model.
- Company has a physical headquarters in Centennial, Colorado.
CBD of Denver Inc. Hissesi: Cevaplanan Temel Sorular
CBDD için değerlendirilmesi gereken temel faktörler nelerdir?
CBD of Denver Inc. (CBDD) şu anda yapay zeka skoru 51/100, orta puanı gösteriyor. Temel güçlü yan: Focus on premium hemp extract products.. İzlenmesi gereken birincil risk: Potential: Intense competition in the CBD market.. Bu bir finansal tavsiye değildir.
CBDD MoonshotScore'u nedir?
CBDD şu anda MoonshotScore'da 51/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
CBDD verileri ne sıklıkla güncellenir?
CBDD fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler CBDD hakkında ne diyor?
CBDD için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
CBDD'a yatırım yapmanın riskleri nelerdir?
CBDD için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition in the CBD market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
CBDD'ın P/E oranı nedir?
CBDD için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CBDD'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
CBDD aşırı değerli mi, yoksa düşük değerli mi?
CBD of Denver Inc. (CBDD)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
CBDD'ın temettü verimi nedir?
CBD of Denver Inc. (CBDD) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Financial data is limited due to the company's OTC listing and disclosure status.
- AI analysis is pending for CBDD.